Case Dismissed: Appeals Court Slams Expert Witness in Diabetes Drug Lawsuits

Multi-district litigation over the diabetes drug saxagliptin, a case that combined more than 80 suits from around the country, has failed because the

Related Keywords

New York ,United States ,Washington ,Kentucky ,Leatha Taylor ,Paul Schmidt ,Goyal Bradford Hill ,Bradford Hill ,Covington Burling ,Ashton Rose Smith ,Parag Goyal ,John Nalbandian ,Bristol Myers Squibb ,Karen Caldwell ,Weill Cornell School Of Medicine ,Drug Administration ,Bristol Myers Squibb Co ,District Court ,Astrazeneca Pharmaceuticals ,Astrazeneca ,Us Circuit Court ,Eastern Kentucky ,Weill Cornell School ,Vascular Outcomes Recorded ,Diabetes Mellitus ,Eastern District ,Circuit Judge John Nalbandian ,Myers Squibb ,